|
|
| n (%) |
| Age, years | Median | 58 (Range 32 - 81) |
| Gender | Male | 17 (40.5%) |
|
| Female | 25 (59.5%) |
| ECOG performance status | 0, 1 | 37 (88.0%) |
|
| 2 | 5 (12.0%) |
| Stage | I | 1 (2.3%) |
|
| II | 2 (4.7%) |
|
| III | 10 (23.0%) |
|
| IV | 29 (69.0%) |
| Histological type | Diffuse | 39 (92.9%) |
|
| Interstitial | 3 (7.1%) |
| HER 2 status | Positive | 2 (4.8%) |
|
| Negative | 40 (95.2%) |
| Gastrectomy | Yes | 20 (52.3%) |
|
| No | 22 (47.7%) |
| Degree of tumor extent | Metastatic | 29 (69.0%) |
|
| Locally advanced | 13 (31.0%) |
| Metastatic site | Peritoneum | 15 (51.7%) |
|
| Abdominal lymph nodes | 7 (24.1%) |
|
| Liver | 1 (3.4%) |
|
| Other | 6 (20.6%) |